Home
Target list
Statistics
Structure galleries
Community nominated targets
Technology development
Web tools and servers
Databases
Participating investigators
Publications
Education and research training
NESG in the news
|
NESG statistics
(data retrieved from targetdb and updated weekly)
PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 12,466 | | 21,190 |
| Expressed (E > 0) | | 9,371 | | 14,544 |
| Expressed-Soluble (ES >= 10) | | 5,484 | | 7,615 |
| Expressed-Insoluble | | 3,887 |
| 6,929 |
| Purified (>= 0.5 mg yield) | | 2,819 | | 3,624 |
| HSQC spectra recorded | | 1,176 | | 1,551 |
| "Good" or "Promising" HSQC spectra | | 654 | | 870 |
| Crystal hits | | 925 | | 1,102 |
| Diffraction data collected | | 366 | | 425 |
| Strong-diffracting crystals (< 4 A) | | 323 | | 377 |

| | | | |
| X-ray crystal structures in PDB | | 414 | | |
| NMR structures in PDB | | 316 | | |
| Resonance assignment to BMRB | | 316 | | |
| Distinct targets in PDB | | 659 | | |
| Total structures in PDB | | 730 | | |
PSI-1 & PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 17,671 | | 28,490 |
| Expressed (E > 0) | | 12,341 | | 18,006 |
| Expressed-Soluble (ES >= 10) | | 7,215 | | 9,583 |
| Expressed-Insoluble | | 5,126 |
| 8,423 |
| Purified (>= 0.5 mg yield) | | 3,911 | | 4,799 |
| HSQC spectra recorded | | 1,982 | | 2,664 |
| "Good" or "Promising" HSQC spectra | | 1,009 | | 1,376 |
| Crystal hits | | 1,144 | | 1,347 |
| Diffraction data collected | | 517 | | 601 |
| Strong-diffracting crystals (< 4 A) | | 467 | | 546 |

| | | | |
| X-ray crystal structures in PDB | | 523 | | |
| NMR structures in PDB | | 399 | | |
| Resonance assignment to BMRB | | 399 | | |
| Distinct targets in PDB | | 834 | | |
| Total structures in PDB | | 922 | | |


PSI-2 assigned BIG Families NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 5,470 | | 8,233 |
| Expressed (E > 0) | | 3,979 | | 5,621 |
| Expressed-Soluble (ES >= 10) | | 2,159 | | 2,821 |
| Expressed-Insoluble | | 1,820 |
| 2,800 |
| Purified (>= 0.5 mg yield) | | 1,087 | | 1,309 |
| HSQC spectra recorded | | 500 | | 603 |
| "Good" or "Promising" HSQC spectra | | 290 | | 351 |
| Crystal hits | | 327 | | 377 |
| Diffraction data collected | | 128 | | 145 |
| Strong-diffracting crystals (< 4 A) | | 105 | | 121 |

| | | | |
| X-ray crystal structures in PDB | | 374 | | |
| NMR structures in PDB | | 263 | | |
| Distinct targets in PDB | | 741 | | |
| Total structures in PDB | | 637 | | |
| Structured BIG Families | | 563 | | |
| Structured BIG Families assigned to NESG | | 110 | | |
HCPIN (Human Cancer Protein Interaction Network) PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 1,190 | | 2,741 |
| Expressed (E > 0) | | 902 | | 1,839 |
| Expressed-Soluble (ES >= 10) | | 461 | | 800 |
| Expressed-Insoluble | | 441 |
| 1,039 |
| Purified (>= 0.5 mg yield) | | 222 | | 349 |
| HSQC spectra recorded | | 127 | | 192 |
| "Good" or "Promising" HSQC spectra | | 78 | | 117 |
| Crystal hits | | 70 | | 85 |
| Diffraction data collected | | 11 | | 13 |
| Strong-diffracting crystals (< 4 A) | | 11 | | 13 |

| | | | |
| X-ray crystal structures in PDB | | 21 | | |
| NMR structures in PDB | | 31 | | |
| Resonance assignment to BMRB | | 31 | | |
| Distinct targets in PDB | | 45 | | |
| Total structures in PDB | | 52 | | |
Human PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 2,342 | | 4,335 |
| Expressed (E > 0) | | 1,513 | | 2,642 |
| Expressed-Soluble (ES >= 10) | | 733 | | 1,130 |
| Expressed-Insoluble | | 780 |
| 1,512 |
| Purified (>= 0.5 mg yield) | | 416 | | 574 |
| HSQC spectra recorded | | 189 | | 271 |
| "Good" or "Promising" HSQC spectra | | 101 | | 151 |
| Crystal hits | | 84 | | 104 |
| Diffraction data collected | | 17 | | 24 |
| Strong-diffracting crystals (< 4 A) | | 17 | | 24 |

| | | | |
| X-ray crystal structures in PDB | | 29 | | |
| NMR structures in PDB | | 42 | | |
| Resonance assignment to BMRB | | 42 | | |
| Distinct targets in PDB | | 62 | | |
| Total structures in PDB | | 71 | | |
Human PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 1,382 | | 3,204 |
| Expressed (E > 0) | | 1,019 | | 2,095 |
| Expressed-Soluble (ES >= 10) | | 520 | | 901 |
| Expressed-Insoluble | | 499 |
| 1,194 |
| Purified (>= 0.5 mg yield) | | 251 | | 397 |
| HSQC spectra recorded | | 134 | | 211 |
| "Good" or "Promising" HSQC spectra | | 81 | | 129 |
| Crystal hits | | 75 | | 91 |
| Diffraction data collected | | 12 | | 15 |
| Strong-diffracting crystals (< 4 A) | | 12 | | 15 |

| | | | |
| X-ray crystal structures in PDB | | 23 | | |
| NMR structures in PDB | | 39 | | |
| Resonance assignment to BMRB | | 39 | | |
| Distinct targets in PDB | | 54 | | |
| Total structures in PDB | | 62 | | |
Eukaryotic PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 3,164 | | 6,063 |
| Expressed (E > 0) | | 1,814 | | 3,165 |
| Expressed-Soluble (ES >= 10) | | 874 | | 1,399 |
| Expressed-Insoluble | | 940 |
| 1,766 |
| Purified (>= 0.5 mg yield) | | 468 | | 647 |
| HSQC spectra recorded | | 344 | | 541 |
| "Good" or "Promising" HSQC spectra | | 144 | | 226 |
| Crystal hits | | 89 | | 111 |
| Diffraction data collected | | 20 | | 29 |
| Strong-diffracting crystals (< 4 A) | | 20 | | 29 |

| | | | |
| X-ray crystal structures in PDB | | 37 | | |
| NMR structures in PDB | | 60 | | |
| Resonance assignment to BMRB | | 60 | | |
| Distinct targets in PDB | | 85 | | |
| Total structures in PDB | | 97 | | |
Eukaryotic PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 1,478 | | 3,499 |
| Expressed (E > 0) | | 1,078 | | 2,210 |
| Expressed-Soluble (ES >= 10) | | 556 | | 964 |
| Expressed-Insoluble | | 522 |
| 1,246 |
| Purified (>= 0.5 mg yield) | | 270 | | 418 |
| HSQC spectra recorded | | 143 | | 224 |
| "Good" or "Promising" HSQC spectra | | 87 | | 137 |
| Crystal hits | | 78 | | 94 |
| Diffraction data collected | | 13 | | 16 |
| Strong-diffracting crystals (< 4 A) | | 13 | | 16 |

| | | | |
| X-ray crystal structures in PDB | | 25 | | |
| NMR structures in PDB | | 51 | | |
| Resonance assignment to BMRB | | 51 | | |
| Distinct targets in PDB | | 67 | | |
| Total structures in PDB | | 76 | | |
Prokaryotic PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 14,593 | | 22,770 |
| Expressed (E > 0) | | 10,585 | | 14,952 |
| Expressed-Soluble (ES >= 10) | | 6,378 | | 8,257 |
| Expressed-Insoluble | | 4,207 |
| 6,695 |
| Purified (>= 0.5 mg yield) | | 3,453 | | 4,165 |
| HSQC spectra recorded | | 1,704 | | 2,244 |
| "Good" or "Promising" HSQC spectra | | 892 | | 1,200 |
| Crystal hits | | 1,057 | | 1,238 |
| Diffraction data collected | | 499 | | 574 |
| Strong-diffracting crystals (< 4 A) | | 449 | | 519 |

| | | | |
| X-ray crystal structures in PDB | | 486 | | |
| NMR structures in PDB | | 339 | | |
| Resonance assignment to BMRB | | 339 | | |
| Distinct targets in PDB | | 749 | | |
| Total structures in PDB | | 825 | | |
Prokaryotic PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 10,989 | | 17,677 |
| Expressed (E > 0) | | 8,294 | | 12,325 |
| Expressed-Soluble (ES >= 10) | | 4,929 | | 6,646 |
| Expressed-Insoluble | | 3,365 |
| 5,679 |
| Purified (>= 0.5 mg yield) | | 2,550 | | 3,206 |
| HSQC spectra recorded | | 1,034 | | 1,327 |
| "Good" or "Promising" HSQC spectra | | 568 | | 733 |
| Crystal hits | | 847 | | 1,008 |
| Diffraction data collected | | 353 | | 409 |
| Strong-diffracting crystals (< 4 A) | | 310 | | 361 |

| | | | |
| X-ray crystal structures in PDB | | 389 | | |
| NMR structures in PDB | | 265 | | |
| Resonance assignment to BMRB | | 265 | | |
| Distinct targets in PDB | | 592 | | |
| Total structures in PDB | | 654 | | |
PSI-1 and PSI-2 Salmonella Protein Production Statistics (NESG Orgs: St, Sl, Sc)
| Production stage | | number of targets | | number of constructs |
| Cloned | | 356 | | 449 |
| Expressed (E > 0) | | 299 | | 361 |
| Expressed-Soluble (ES >= 10) | | 181 | | 212 |
| Expressed-Insoluble | | 118 |
| 149 |
| Purified (>= 0.5 mg yield) | | 111 | | 124 |
| HSQC spectra recorded | | 44 | | 48 |
| "Good" or "Promising" HSQC spectra | | 28 | | 28 |
| Crystal hits | | 30 | | 33 |
| Diffraction data collected | | 14 | | 15 |
| Strong-diffracting crystals (< 4 A) | | 13 | | 14 |

| | | | |
| X-ray crystal structures in PDB | | 10 | | |
| NMR structures in PDB | | 11 | | |
| Resonance assignment to BMRB | | 11 | | |
| Distinct targets in PDB | | 17 | | |
| Total structures in PDB | | 21 | | |
PSI-1 and PSI-2 transcription factors
| Production stage | | number of targets | | number of constructs |
| Cloned | | 207 | | 443 |
| Expressed (E > 0) | | 145 | | 278 |
| Expressed-Soluble (ES >= 10) | | 91 | | 160 |
| Expressed-Insoluble | | 54 |
| 118 |
| Purified (>= 0.5 mg yield) | | 37 | | 55 |
| HSQC spectra recorded | | 31 | | 40 |
| "Good" or "Promising" HSQC spectra | | 18 | | 25 |
| Crystal hits | | 13 | | 13 |
| Diffraction data collected | | 0 | | 0 |
| Strong-diffracting crystals (< 4 A) | | 0 | | 0 |

| | | | |
| X-ray crystal structures in PDB | | 3 | | |
| NMR structures in PDB | | 3 | | |
| Resonance assignment to BMRB | | 3 | | |
| Distinct targets in PDB | | 5 | | |
| Total structures in PDB | | 6 | | |
OB fold (2.40.50.140) PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 331 | | 502 |
| Expressed (E > 0) | | 273 | | 370 |
| Expressed-Soluble (ES >= 10) | | 213 | | 277 |
| Expressed-Insoluble | | 60 |
| 93 |
| Purified (>= 0.5 mg yield) | | 128 | | 156 |
| HSQC spectra recorded | | 70 | | 89 |
| "Good" or "Promising" HSQC spectra | | 35 | | 45 |
| Crystal hits | | 35 | | 39 |
| Diffraction data collected | | 15 | | 16 |
| Strong-diffracting crystals (< 4 A) | | 10 | | 11 |

| | | | |
| X-ray crystal structures in PDB | | 12 | | |
| NMR structures in PDB | | 14 | | |
| Resonance assignment to BMRB | | 14 | | |
| Distinct targets in PDB | | 23 | | |
| Total structures in PDB | | 26 | | |
OB fold (2.40.50.140) PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 315 | | 477 |
| Expressed (E > 0) | | 263 | | 357 |
| Expressed-Soluble (ES >= 10) | | 206 | | 268 |
| Expressed-Insoluble | | 57 |
| 89 |
| Purified (>= 0.5 mg yield) | | 123 | | 151 |
| HSQC spectra recorded | | 62 | | 78 |
| "Good" or "Promising" HSQC spectra | | 28 | | 35 |
| Crystal hits | | 35 | | 39 |
| Diffraction data collected | | 15 | | 16 |
| Strong-diffracting crystals (< 4 A) | | 10 | | 11 |

| | | | |
| X-ray crystal structures in PDB | | 12 | | |
| NMR structures in PDB | | 11 | | |
| Resonance assignment to BMRB | | 11 | | |
| Distinct targets in PDB | | 20 | | |
| Total structures in PDB | | 23 | | |
Oxidoreductase (3.50.50.60) PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 633 | | 727 |
| Expressed (E > 0) | | 468 | | 533 |
| Expressed-Soluble (ES >= 10) | | 221 | | 245 |
| Expressed-Insoluble | | 247 |
| 288 |
| Purified (>= 0.5 mg yield) | | 115 | | 126 |
| HSQC spectra recorded | | 3 | | 4 |
| "Good" or "Promising" HSQC spectra | | 0 | | 0 |
| Crystal hits | | 34 | | 36 |
| Diffraction data collected | | 12 | | 12 |
| Strong-diffracting crystals (< 4 A) | | 12 | | 12 |

| | | | |
| X-ray crystal structures in PDB | | 11 | | |
| NMR structures in PDB | | 0 | | |
| Resonance assignment to BMRB | | 0 | | |
| Distinct targets in PDB | | 11 | | |
| Total structures in PDB | | 11 | | |
Oxidoreductase (3.50.50.60) PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 605 | | 694 |
| Expressed (E > 0) | | 453 | | 517 |
| Expressed-Soluble (ES >= 10) | | 216 | | 239 |
| Expressed-Insoluble | | 237 |
| 278 |
| Purified (>= 0.5 mg yield) | | 110 | | 120 |
| HSQC spectra recorded | | 2 | | 2 |
| "Good" or "Promising" HSQC spectra | | 0 | | 0 |
| Crystal hits | | 33 | | 35 |
| Diffraction data collected | | 11 | | 11 |
| Strong-diffracting crystals (< 4 A) | | 11 | | 11 |

| | | | |
| X-ray crystal structures in PDB | | 11 | | |
| NMR structures in PDB | | 0 | | |
| Resonance assignment to BMRB | | 0 | | |
| Distinct targets in PDB | | 11 | | |
| Total structures in PDB | | 11 | | |
Ubiquitin (3.10.20.90) PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 61 | | 163 |
| Expressed (E > 0) | | 50 | | 104 |
| Expressed-Soluble (ES >= 10) | | 33 | | 58 |
| Expressed-Insoluble | | 17 |
| 46 |
| Purified (>= 0.5 mg yield) | | 18 | | 27 |
| HSQC spectra recorded | | 17 | | 22 |
| "Good" or "Promising" HSQC spectra | | 14 | | 19 |
| Crystal hits | | 5 | | 7 |
| Diffraction data collected | | 0 | | 0 |
| Strong-diffracting crystals (< 4 A) | | 0 | | 0 |

| | | | |
| X-ray crystal structures in PDB | | 1 | | |
| NMR structures in PDB | | 13 | | |
| Resonance assignment to BMRB | | 13 | | |
| Distinct targets in PDB | | 13 | | |
| Total structures in PDB | | 14 | | |
Ubiquitin (3.10.20.90) PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 52 | | 140 |
| Expressed (E > 0) | | 43 | | 88 |
| Expressed-Soluble (ES >= 10) | | 27 | | 46 |
| Expressed-Insoluble | | 16 |
| 42 |
| Purified (>= 0.5 mg yield) | | 16 | | 24 |
| HSQC spectra recorded | | 12 | | 16 |
| "Good" or "Promising" HSQC spectra | | 10 | | 14 |
| Crystal hits | | 5 | | 7 |
| Diffraction data collected | | 0 | | 0 |
| Strong-diffracting crystals (< 4 A) | | 0 | | 0 |

| | | | |
| X-ray crystal structures in PDB | | 1 | | |
| NMR structures in PDB | | 11 | | |
| Resonance assignment to BMRB | | 11 | | |
| Distinct targets in PDB | | 11 | | |
| Total structures in PDB | | 12 | | |
Start domain (3.30.530.20) PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 196 | | 288 |
| Expressed (E > 0) | | 167 | | 230 |
| Expressed-Soluble (ES >= 10) | | 124 | | 150 |
| Expressed-Insoluble | | 43 |
| 80 |
| Purified (>= 0.5 mg yield) | | 66 | | 73 |
| HSQC spectra recorded | | 24 | | 24 |
| "Good" or "Promising" HSQC spectra | | 17 | | 17 |
| Crystal hits | | 13 | | 13 |
| Diffraction data collected | | 6 | | 6 |
| Strong-diffracting crystals (< 4 A) | | 6 | | 6 |

| | | | |
| X-ray crystal structures in PDB | | 7 | | |
| NMR structures in PDB | | 8 | | |
| Resonance assignment to BMRB | | 8 | | |
| Distinct targets in PDB | | 13 | | |
| Total structures in PDB | | 15 | | |
Start domain (3.30.530.20) PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 166 | | 253 |
| Expressed (E > 0) | | 145 | | 208 |
| Expressed-Soluble (ES >= 10) | | 105 | | 131 |
| Expressed-Insoluble | | 40 |
| 77 |
| Purified (>= 0.5 mg yield) | | 55 | | 62 |
| HSQC spectra recorded | | 15 | | 15 |
| "Good" or "Promising" HSQC spectra | | 8 | | 8 |
| Crystal hits | | 9 | | 9 |
| Diffraction data collected | | 4 | | 4 |
| Strong-diffracting crystals (< 4 A) | | 4 | | 4 |

| | | | |
| X-ray crystal structures in PDB | | 4 | | |
| NMR structures in PDB | | 5 | | |
| Resonance assignment to BMRB | | 5 | | |
| Distinct targets in PDB | | 7 | | |
| Total structures in PDB | | 9 | | |
Tol-B (2.120.10.30) PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 144 | | 261 |
| Expressed (E > 0) | | 116 | | 192 |
| Expressed-Soluble (ES >= 10) | | 58 | | 83 |
| Expressed-Insoluble | | 58 |
| 109 |
| Purified (>= 0.5 mg yield) | | 31 | | 38 |
| HSQC spectra recorded | | 0 | | 0 |
| "Good" or "Promising" HSQC spectra | | 0 | | 0 |
| Crystal hits | | 15 | | 15 |
| Diffraction data collected | | 6 | | 6 |
| Strong-diffracting crystals (< 4 A) | | 6 | | 6 |

| | | | |
| X-ray crystal structures in PDB | | 6 | | |
| NMR structures in PDB | | 0 | | |
| Resonance assignment to BMRB | | 0 | | |
| Distinct targets in PDB | | 6 | | |
| Total structures in PDB | | 6 | | |
Tol-B (2.120.10.30) PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 141 | | 257 |
| Expressed (E > 0) | | 115 | | 191 |
| Expressed-Soluble (ES >= 10) | | 57 | | 82 |
| Expressed-Insoluble | | 58 |
| 109 |
| Purified (>= 0.5 mg yield) | | 31 | | 38 |
| HSQC spectra recorded | | 0 | | 0 |
| "Good" or "Promising" HSQC spectra | | 0 | | 0 |
| Crystal hits | | 15 | | 15 |
| Diffraction data collected | | 6 | | 6 |
| Strong-diffracting crystals (< 4 A) | | 6 | | 6 |

| | | | |
| X-ray crystal structures in PDB | | 6 | | |
| NMR structures in PDB | | 0 | | |
| Resonance assignment to BMRB | | 0 | | |
| Distinct targets in PDB | | 6 | | |
| Total structures in PDB | | 6 | | |
Ubiquitin E2 (3.10.110.10) PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 12 | | 22 |
| Expressed (E > 0) | | 7 | | 10 |
| Expressed-Soluble (ES >= 10) | | 2 | | 3 |
| Expressed-Insoluble | | 5 |
| 7 |
| Purified (>= 0.5 mg yield) | | 2 | | 3 |
| HSQC spectra recorded | | 0 | | 0 |
| "Good" or "Promising" HSQC spectra | | 0 | | 0 |
| Crystal hits | | 0 | | 0 |
| Diffraction data collected | | 0 | | 0 |
| Strong-diffracting crystals (< 4 A) | | 0 | | 0 |

| | | | |
| X-ray crystal structures in PDB | | 0 | | |
| NMR structures in PDB | | 0 | | |
| Resonance assignment to BMRB | | 0 | | |
| Distinct targets in PDB | | 0 | | |
| Total structures in PDB | | 0 | | |
Ubiquitin E2 (3.10.110.10) PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 5 | | 10 |
| Expressed (E > 0) | | 4 | | 6 |
| Expressed-Soluble (ES >= 10) | | 2 | | 3 |
| Expressed-Insoluble | | 2 |
| 3 |
| Purified (>= 0.5 mg yield) | | 0 | | 0 |
| HSQC spectra recorded | | 0 | | 0 |
| "Good" or "Promising" HSQC spectra | | 0 | | 0 |
| Crystal hits | | 0 | | 0 |
| Diffraction data collected | | 0 | | 0 |
| Strong-diffracting crystals (< 4 A) | | 0 | | 0 |

| | | | |
| X-ray crystal structures in PDB | | 0 | | |
| NMR structures in PDB | | 0 | | |
| Resonance assignment to BMRB | | 0 | | |
| Distinct targets in PDB | | 0 | | |
| Total structures in PDB | | 0 | | |
Polysaccharide Biosynthesis (3.90.550.10) PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 449 | | 524 |
| Expressed (E > 0) | | 315 | | 355 |
| Expressed-Soluble (ES >= 10) | | 188 | | 192 |
| Expressed-Insoluble | | 127 |
| 163 |
| Purified (>= 0.5 mg yield) | | 40 | | 40 |
| HSQC spectra recorded | | 0 | | 0 |
| "Good" or "Promising" HSQC spectra | | 0 | | 0 |
| Crystal hits | | 9 | | 9 |
| Diffraction data collected | | 3 | | 3 |
| Strong-diffracting crystals (< 4 A) | | 2 | | 2 |

| | | | |
| X-ray crystal structures in PDB | | 5 | | |
| NMR structures in PDB | | 0 | | |
| Resonance assignment to BMRB | | 0 | | |
| Distinct targets in PDB | | 4 | | |
| Total structures in PDB | | 5 | | |
Polysaccharide Biosynthesis (3.90.550.10) PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 443 | | 516 |
| Expressed (E > 0) | | 310 | | 349 |
| Expressed-Soluble (ES >= 10) | | 186 | | 190 |
| Expressed-Insoluble | | 124 |
| 159 |
| Purified (>= 0.5 mg yield) | | 38 | | 38 |
| HSQC spectra recorded | | 0 | | 0 |
| "Good" or "Promising" HSQC spectra | | 0 | | 0 |
| Crystal hits | | 8 | | 8 |
| Diffraction data collected | | 2 | | 2 |
| Strong-diffracting crystals (< 4 A) | | 1 | | 1 |

| | | | |
| X-ray crystal structures in PDB | | 4 | | |
| NMR structures in PDB | | 0 | | |
| Resonance assignment to BMRB | | 0 | | |
| Distinct targets in PDB | | 3 | | |
| Total structures in PDB | | 4 | | |
P-loop (3.40.50.300) PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 860 | | 1,186 |
| Expressed (E > 0) | | 648 | | 847 |
| Expressed-Soluble (ES >= 10) | | 377 | | 409 |
| Expressed-Insoluble | | 271 |
| 438 |
| Purified (>= 0.5 mg yield) | | 212 | | 225 |
| HSQC spectra recorded | | 37 | | 40 |
| "Good" or "Promising" HSQC spectra | | 11 | | 12 |
| Crystal hits | | 62 | | 65 |
| Diffraction data collected | | 26 | | 27 |
| Strong-diffracting crystals (< 4 A) | | 20 | | 21 |

| | | | |
| X-ray crystal structures in PDB | | 16 | | |
| NMR structures in PDB | | 2 | | |
| Resonance assignment to BMRB | | 2 | | |
| Distinct targets in PDB | | 15 | | |
| Total structures in PDB | | 18 | | |
P-loop (3.40.50.300) PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 704 | | 988 |
| Expressed (E > 0) | | 551 | | 745 |
| Expressed-Soluble (ES >= 10) | | 315 | | 347 |
| Expressed-Insoluble | | 236 |
| 398 |
| Purified (>= 0.5 mg yield) | | 164 | | 177 |
| HSQC spectra recorded | | 11 | | 12 |
| "Good" or "Promising" HSQC spectra | | 6 | | 7 |
| Crystal hits | | 50 | | 53 |
| Diffraction data collected | | 18 | | 19 |
| Strong-diffracting crystals (< 4 A) | | 13 | | 14 |

| | | | |
| X-ray crystal structures in PDB | | 13 | | |
| NMR structures in PDB | | 2 | | |
| Resonance assignment to BMRB | | 2 | | |
| Distinct targets in PDB | | 12 | | |
| Total structures in PDB | | 15 | | |
NAD(P) binding domain (3.40.50.720) PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 824 | | 1,000 |
| Expressed (E > 0) | | 621 | | 735 |
| Expressed-Soluble (ES >= 10) | | 335 | | 383 |
| Expressed-Insoluble | | 286 |
| 352 |
| Purified (>= 0.5 mg yield) | | 186 | | 211 |
| HSQC spectra recorded | | 17 | | 18 |
| "Good" or "Promising" HSQC spectra | | 7 | | 7 |
| Crystal hits | | 60 | | 68 |
| Diffraction data collected | | 29 | | 34 |
| Strong-diffracting crystals (< 4 A) | | 28 | | 32 |

| | | | |
| X-ray crystal structures in PDB | | 26 | | |
| NMR structures in PDB | | 1 | | |
| Resonance assignment to BMRB | | 1 | | |
| Distinct targets in PDB | | 25 | | |
| Total structures in PDB | | 27 | | |
NAD(P) binding domain (3.40.50.720) PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 733 | | 884 |
| Expressed (E > 0) | | 565 | | 673 |
| Expressed-Soluble (ES >= 10) | | 298 | | 343 |
| Expressed-Insoluble | | 267 |
| 330 |
| Purified (>= 0.5 mg yield) | | 162 | | 183 |
| HSQC spectra recorded | | 8 | | 8 |
| "Good" or "Promising" HSQC spectra | | 6 | | 6 |
| Crystal hits | | 54 | | 61 |
| Diffraction data collected | | 25 | | 29 |
| Strong-diffracting crystals (< 4 A) | | 24 | | 27 |

| | | | |
| X-ray crystal structures in PDB | | 24 | | |
| NMR structures in PDB | | 1 | | |
| Resonance assignment to BMRB | | 1 | | |
| Distinct targets in PDB | | 23 | | |
| Total structures in PDB | | 25 | | |
Aldolase class I (3.20.20.70) PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 324 | | 467 |
| Expressed (E > 0) | | 228 | | 301 |
| Expressed-Soluble (ES >= 10) | | 125 | | 138 |
| Expressed-Insoluble | | 103 |
| 163 |
| Purified (>= 0.5 mg yield) | | 73 | | 79 |
| HSQC spectra recorded | | 11 | | 12 |
| "Good" or "Promising" HSQC spectra | | 3 | | 3 |
| Crystal hits | | 20 | | 21 |
| Diffraction data collected | | 11 | | 12 |
| Strong-diffracting crystals (< 4 A) | | 10 | | 11 |

| | | | |
| X-ray crystal structures in PDB | | 11 | | |
| NMR structures in PDB | | 0 | | |
| Resonance assignment to BMRB | | 0 | | |
| Distinct targets in PDB | | 11 | | |
| Total structures in PDB | | 11 | | |
Aldolase class I (3.20.20.70) PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 177 | | 261 |
| Expressed (E > 0) | | 145 | | 207 |
| Expressed-Soluble (ES >= 10) | | 78 | | 88 |
| Expressed-Insoluble | | 67 |
| 119 |
| Purified (>= 0.5 mg yield) | | 47 | | 52 |
| HSQC spectra recorded | | 3 | | 4 |
| "Good" or "Promising" HSQC spectra | | 1 | | 1 |
| Crystal hits | | 12 | | 12 |
| Diffraction data collected | | 5 | | 5 |
| Strong-diffracting crystals (< 4 A) | | 5 | | 5 |

| | | | |
| X-ray crystal structures in PDB | | 5 | | |
| NMR structures in PDB | | 0 | | |
| Resonance assignment to BMRB | | 0 | | |
| Distinct targets in PDB | | 5 | | |
| Total structures in PDB | | 5 | | |
Vaccinia Virus protein VP39 (3.40.50.150) PSI-1 and PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 360 | | 565 |
| Expressed (E > 0) | | 277 | | 392 |
| Expressed-Soluble (ES >= 10) | | 174 | | 204 |
| Expressed-Insoluble | | 103 |
| 188 |
| Purified (>= 0.5 mg yield) | | 93 | | 103 |
| HSQC spectra recorded | | 19 | | 19 |
| "Good" or "Promising" HSQC spectra | | 9 | | 9 |
| Crystal hits | | 32 | | 36 |
| Diffraction data collected | | 18 | | 19 |
| Strong-diffracting crystals (< 4 A) | | 15 | | 15 |

| | | | |
| X-ray crystal structures in PDB | | 19 | | |
| NMR structures in PDB | | 1 | | |
| Resonance assignment to BMRB | | 1 | | |
| Distinct targets in PDB | | 18 | | |
| Total structures in PDB | | 20 | | |
Vaccinia Virus protein VP39 (3.40.50.150) PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 254 | | 423 |
| Expressed (E > 0) | | 208 | | 317 |
| Expressed-Soluble (ES >= 10) | | 143 | | 172 |
| Expressed-Insoluble | | 65 |
| 145 |
| Purified (>= 0.5 mg yield) | | 72 | | 81 |
| HSQC spectra recorded | | 9 | | 9 |
| "Good" or "Promising" HSQC spectra | | 5 | | 5 |
| Crystal hits | | 28 | | 32 |
| Diffraction data collected | | 16 | | 17 |
| Strong-diffracting crystals (< 4 A) | | 13 | | 13 |

| | | | |
| X-ray crystal structures in PDB | | 15 | | |
| NMR structures in PDB | | 1 | | |
| Resonance assignment to BMRB | | 1 | | |
| Distinct targets in PDB | | 14 | | |
| Total structures in PDB | | 16 | | |
Metagenomic targets PSI-2 NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 1,056 | | 1,801 |
| Expressed (E > 0) | | 887 | | 1,390 |
| Expressed-Soluble (ES >= 10) | | 594 | | 838 |
| Expressed-Insoluble | | 293 |
| 552 |
| Purified (>= 0.5 mg yield) | | 342 | | 426 |
| HSQC spectra recorded | | 111 | | 131 |
| "Good" or "Promising" HSQC spectra | | 75 | | 87 |
| Crystal hits | | 110 | | 121 |
| Diffraction data collected | | 36 | | 37 |
| Strong-diffracting crystals (< 4 A) | | 35 | | 36 |

| | | | |
| X-ray crystal structures in PDB | | 39 | | |
| NMR structures in PDB | | 25 | | |
| Resonance assignment to BMRB | | 25 | | |
| Distinct targets in PDB | | 56 | | |
| Total structures in PDB | | 64 | | |
MCSG salvage targets NESG Protein Production Statistics
| Production stage | | number of targets | | number of constructs |
| Cloned | | 53 | | 60 |
| Expressed (E > 0) | | 47 | | 49 |
| Expressed-Soluble (ES >= 10) | | 34 | | 36 |
| Expressed-Insoluble | | 13 |
| 13 |
| Purified (>= 0.5 mg yield) | | 28 | | 30 |
| HSQC spectra recorded | | 26 | | 26 |
| "Good" or "Promising" HSQC spectra | | 13 | | 13 |
| Crystal hits | | 7 | | 7 |
| Diffraction data collected | | 3 | | 3 |
| Strong-diffracting crystals (< 4 A) | | 3 | | 3 |

| | | | |
| X-ray crystal structures in PDB | | 3 | | |
| NMR structures in PDB | | 7 | | |
| Resonance assignment to BMRB | | 7 | | |
| Distinct targets in PDB | | 7 | | |
| Total structures in PDB | | 10 | | |
Year 5 BIG OPEN project (2009-03-01 - present)
| Production stage | | number of targets | | number of constructs |
| Cloned | | 1,569 | | 3,647 |
| Expressed (E > 0) | | 1,136 | | 2,333 |
| Expressed-Soluble (ES >= 10) | | 598 | | 1,042 |
| Expressed-Insoluble | | 538 |
| 1,291 |
| Purified (>= 0.5 mg yield) | | 272 | | 417 |
| HSQC spectra recorded | | 120 | | 165 |
| "Good" or "Promising" HSQC spectra | | 78 | | 99 |
| Crystal hits | | 93 | | 119 |
| Diffraction data collected | | 17 | | 23 |
| Strong-diffracting crystals (< 4 A) | | 16 | | 22 |

| | | | |
| X-ray crystal structures in PDB | | 29 | | |
| NMR structures in PDB | | 30 | | |
| Resonance assignment to BMRB | | 30 | | |
| Distinct targets in PDB | | 53 | | |
| Total structures in PDB | | 59 | | |
|